Jiangsu Bioperfectus Technologies Co., Ltd. was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange on December 5, 2019

Company news
2019-12-05

Jiangsu Bioperfectus Technologies Co., Ltd. (abbreviated as "Bioperfectus", with stock code "688399") was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange on December 5, 2019, with an issue price of 46.78 yuan.

Bioperfectus' revenue in the first nine months of 2019 was 190 million yuan, an increase of 20.25% over the same period last year; net profit was 49.77 million yuan, an increase of 26.53% over the same period last year.

From 2010 to 2019, for ten years, upholding the original intention of solving practical clinical problems and innovating disease diagnosis technology, Bioperfectus people have worked hard and arduously, finally making Bioperfectus one of the leading in vitro diagnostic companies in China.


In the future, we Bioperfectus will continue to bear our original intention in mind, work hard and move forward bravely!

MOST READ

Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

2022-11-30

Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.

2022-11-15

Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).

2022-11-14